News | July 26, 2022
Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
Better serving global partners and advancing healthcare innovation
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
Manish led SeQuent since 2014 and played a major role in transforming the company
Subscribe To Our Newsletter & Stay Updated
